Paramount Agencies
⚠️ Moderate Risk
FEI: 3007132654 • Karachi • PAKISTAN
FEI Number
3007132654
Location
Karachi
Country
PAKISTANAddress
Sadar Center 322 Serai Road, , Karachi, , Pakistan
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
COLOR LBLG
The article appears to contain an artificial coloring and it fails to bear labeling stating that fact.
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
COSM COLOR
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain a color additive which is unsafe within the meaning of Section 721(a) which renders it adulterated under Section 601(e).
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
HEALTH C
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/20/2011 | 31KYT04TEA, MIXED (GREEN AND BLACK, ETC.) | 488HEALTH C | Atlanta District Office (ATL-DO) |
| 12/20/2011 | 03HGT08BUTTER/BUTTER FLAVORED,PLAIN COOKIES,BISCUITS AND WAFERS | Atlanta District Office (ATL-DO) | |
| 12/20/2011 | 03HGT02CHOCOLATE PLAIN COOKIES,BISCUITS AND WAFERS | Atlanta District Office (ATL-DO) | |
| 12/20/2011 | 53IH01DENTIFRICES (AEROSOL, LIQUID, TOOTHPASTES, TOOTHPOWDERS), WITHOUT FLUORIDE (ORAL HYGIENE PRODUCTS) | 218LIST INGRE | Atlanta District Office (ATL-DO) |
| 12/20/2011 | 53CY02EYELINER (EYE MAKEUP PREPARATIONS) | 197COSM COLOR | Atlanta District Office (ATL-DO) |
| 12/20/2011 | 53ED01HAIR CONDITIONERS (HAIR PREPARATIONS, NON-COLORING) | 75UNAPPROVED | Atlanta District Office (ATL-DO) |
Frequently Asked Questions
What is Paramount Agencies's FDA import refusal history?
Paramount Agencies (FEI: 3007132654) has 6 FDA import refusal record(s) in our database, spanning from 12/20/2011 to 12/20/2011.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Paramount Agencies's FEI number is 3007132654.
What types of violations has Paramount Agencies received?
Paramount Agencies has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Paramount Agencies come from?
All FDA import refusal data for Paramount Agencies is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.